Redwood City, California 94043

  • Complex Regional Pain Syndromes


The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.


Inclusion Criteria: - Age 18-70 - Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months - Average pain level reported on Numerical Rating Scale meets entry criteria - Ability to perform the experimental task and procedures. Exclusion Criteria: - MRI contraindication (metal implants or devices, claustrophobia) - TMS Contraindication (eg metal implant or devices near the site of stimulation) - History of epilepsy - History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher. - Neurologic illness that would interfere with brain integrity - Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher. - Currently pregnant or planning to become pregnant. - On going legal action or disability claim.



Primary Contact:

Birute Gedrimaite
Phone: (650) 497-0485

Backup Contact:


Location Contact:

Redwood City, California 94043
United States

Birute Gedrimaite
Phone: 650-497-0485

Site Status: Recruiting

Data Source:

Date Processed: September 17, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.